Skip to main content
Log in

Impact of QALY-equivalence assumptions on vaccine cost effectiveness

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. National Immunization Technical Advisory Groups

Reference

  • Luyten J, et al. Integrating Alternative Social Value Judgments Into Cost-Effectiveness Analysis of Vaccines: An Application to Varicella-Zoster Virus Vaccination. Value in Health : 13 Nov 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.07.011

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Impact of QALY-equivalence assumptions on vaccine cost effectiveness. PharmacoEcon Outcomes News 867, 18 (2020). https://doi.org/10.1007/s40274-020-7315-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7315-2

Navigation